White Paper - Companion Diagnostic Development: An Overview Xenium In Situ Services are Now Available Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments Advancing In Vitro Disease Modeling with Mouse Hepatocytes for Gene Therapy

White Paper - Companion Diagnostic Development: An Overview Xenium In Situ Services are Now Available Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments Advancing In Vitro Disease Modeling with Mouse Hepatocytes for Gene Therapy

Quantitative Gene Expression Analysis

Sensitive, high-throughput, and quantitative,
gene expression analysis

Discovery’s expert scientists work collaboratively with you to plan experimental design, ensure standardized sample handling, and help you analyze data to propel your drug and diagnostic programs forward faster. Our services are highly customizable and flexible so we can tailor them to your unique study goals.

Expertise

Decades of experience developing, validating and applying biomarker assays throughout every stage of development for leading biotech and pharma clients.

Technology

A technology agnostic approach to enable an unbiased selection of the most suitable platforms .

Compliance & Quality

Specialty testing in CLIA-certified, CAP accredited, and GCLP compliant service laboratories to support concurrent clinical trials and regulatory submissions.

Health Institution status of Discovery’s laboratory in Germany confirmed by German Regional Council.

Global Harmonization

Global standardization and harmonization of assays including global clinical trial testing and our Biomarker Academy™ training programs with post-approval services.

Access to Clinical Specimens

Access to the world’s largest commercial biorepository to build optimal study cohorts.

Rapid Orthogonal Testing

Optimized multi-omic integration with clinical flow, cell biology, genomic, and proteomic services – all under one roof.

Quantitative Gene Expression

Technology Platforms

Discovery provides a wide range of technology platforms for quantitative gene expression analysis. This allows you to choose the most suitable platform based on your specific needs, such as high-throughput sequencing, real-time PCR, or other advanced techniques.

NanoString

PCR

Other Applications

Biomarker discovery and validation
Target identification and validation
Elucidate a drug's mode of action
Pharmacogenomics and patient stratification
Toxicity assessments
Companion diagnostics development
Clinical trial monitoring
Comprehensively understand molecular signatures
Perform correlation studies using IHC, NGS, scNGS, and other technologies to enhance insights

Contact Us Today

Privacy Settings